Barclays’s Apogee Therapeutics APGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $26.4M | Buy |
608,822
+110,197
| +22% | +$4.79M | 0.01% | 706 |
|
|
2025
Q1 | $18.6M | Buy |
498,625
+21,865
| +5% | +$817K | 0.01% | 765 |
|
|
2024
Q4 | $21.6M | Buy |
476,760
+111,714
| +31% | +$5.06M | 0.01% | 751 |
|
|
2024
Q3 | $21.4M | Buy |
365,046
+287,243
| +369% | +$16.9M | 0.01% | 724 |
|
|
2024
Q2 | $3.06M | Buy |
77,803
+41,157
| +112% | +$1.62M | ﹤0.01% | 1432 |
|
|
2024
Q1 | $2.44M | Buy |
36,646
+2,590
| +8% | +$172K | ﹤0.01% | 1808 |
|
|
2023
Q4 | $952K | Buy |
+34,056
| New | +$952K | ﹤0.01% | 2630 |
|